Home LiteratureArticle Details
PMID: 6699654 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The effect of Freund's adjuvants on blood-cerebrospinal fluid barrier permeability.

Journal of the neurological sciences ·Vol. 63 ·No. 1 ·1984-01-00 ·Pages 55-61

Reiber H, Suckling AJ, Rumsby MG

Abstract

In guinea pigs with experimental allergic encephalomyelitis induced by spinal cord homogenate--complete Freund's adjuvant (CFA) emulsions an increase in the albumin permeability of the blood--cerebrospinal fluid barrier occurred from day 10 post-inoculation (p.i.) onward. In animals inoculated with CFA alone an increased albumin permeability was also demonstrated but only between days 5 and 10 after inoculation; by day 14-16 p.i. the barrier permeability had returned to control values. A similar change was seen in animals inoculated with incomplete Freund's adjuvant (IFA) only. However, both CFA and CFA-cord induced a strong humoral immune response which was not seen in animals inoculated with IFA alone. These results may have important consequences for the understanding of the development of inflammatory diseases of the central nervous system.

MeSH Terms
Animals Blood-Brain Barrier/drug effects Encephalomyelitis, Autoimmune, Experimental/metabolism Freund's Adjuvant/pharmacology Guinea Pigs Immunoglobulin G/metabolism Serum Albumin/metabolism
Chemicals
Immunoglobulin G Serum Albumin Freund's Adjuvant
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Reiber H
Suckling A J
Rumsby M G
Article Info
Journal
Journal of the neurological sciences
Abbr.
J Neurol Sci
ISSN
0022-510X
Published
1984-01-00
Pages
55-61
Language
English
Region
Netherlands
NLM ID
0375403
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com